GlaxoSmithKline (GSK) Reports Q1 EPS of GBP0.19; Lowers FY14 EPS Growth Outlook

Go back to GlaxoSmithKline (GSK) Reports Q1 EPS of GBP0.19; Lowers FY14 EPS Growth Outlook

InterMune (ITMN) Higher on Takeover Chatter

July 21, 2014 10:37 AM EDT

InterMune (NASDAQ: ITMN) is solidly higher today (+3.9%) following reports from Betaville over the weekend that GlaxoSmithKline plc (NYSE: GSK) is exploring a takeover of the company.

"Good sources tell me the FTSE 100 giant has... More